Janet Woodcock
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Biomedical Ethics and Regulation, Biosimilars and Bioanalytical Methods, Pharmaceutical studies and practices
Most-Cited Works
- → Real-World Evidence — What Is It and What Can It Tell Us?(2016)1,989 cited
- → Understanding Pharmaceutical Quality by Design(2014)1,330 cited
- → Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both(2017)960 cited
- → Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production(2015)838 cited
- → Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives(2010)628 cited
- → Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System(2008)614 cited
- → Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events(2008)614 cited